Upcoming CA17140 2nd Training school

Dear COSTers,

we are pleased to announce our upcoming CA17140 2nd Training School, entitled: Preclinical and clinical methods in cancer nanomedicine research.
The School will be held on March 13-14, 2023 at the Institute of Oncology Research (IOR), Bellinzona, Switzerland.

The field of nanomedicine has seen substantial progress in the last few years. Many products have reached the market or are under clinical investigation, and many more nanomedicine-based therapeutics are in development and undergoing preclinical evaluation. Nanomedicine may revolutionize cancer treatment, moving it toward the era of precision cancer medicine.
Improving methods and approaches for preclinical and clinical investigation is a strategic need for the nanomedicine field, particularly for oncological applications. The 2-day Training School, organized by WG3 and WG4 of the Nano2Clinic COST Action, will feature presentations and practical sessions on the methodological approaches and technologies available for advanced preclinical and clinical studies of cancer nanomedicines and an overview of the stakeholders in the field at academic and industrial levels. The intent is to provide an opportunity for young scientists to interact with expert researchers and discuss various techniques and applications, from the biological and functional characterization of nanomaterials to anticancer efficacy studies in cell cultures and in vivo models and the planning of early-phase clinical trials.

All interested participants are strongly invited to use the registration form, available for download from this page, and follow the instructions therein to submit their application.

The deadline to submit the registration form for the training school is 15th January 2023, and the number of available COST grants to attend the school is limited! So hurry up and good luck.


European Cooperation in Science and Technology (COST) logo
Funded by the European Union